Gilead Sciences Inc. recently disclosed details on the work that led to the discovery of elunonavir (GS-1156), an unboosted HIV protease inhibitor currently in phase I studies.
More than 40 years of AIDS research has led to significant advancements in treatment and prevention. Drugs to treat the infection continued to improve, as did patient outcomes. But now there's another ...
On June 5, 1981, national health experts published accounts of a strange infection circulating around Los Angeles. The U.S. Centers for Disease Control and Prevention (CDC) reported on that day that, ...
World Health Organization releases updated recommendations on HIV clinical management: Geneva Thursday, January 8, 2026, 10:00 Hrs [IST] The World Health Organization (WHO) has re ...
WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...
Hepatitis C infection. Computer illustration showing liver and close-up view of hepatitis C viruses. Studies show that mortality, morbidity, and hepatic decompensation risks increase with coinfection ...
Over the past century, several pathogenic viruses have entered the human population, including human immunodeficiency virus type 1 (HIV-1). HIV-1 became a pandemic following the successful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback